Custom-made cancer cell attacks

	Tweet

Imagine a cancer treatment tailored to the cells in a patient’s body, each person receiving a unique treatment program.

This is what Natural Sciences and Engineering Research Council grantee Thomas Ruth and his colleagues hope to accomplish within the next decade. Using the TRIUMF particle accelerator based in Vancouver, British Columbia, they are taking vast amounts of radioactive material and separating the particular atoms they need for therapy.

Ruth says radioisotope therapy is the next big frontier in health care because different types of chemicals can be selected for tailor-made treatment programs. This is because radioactive chemicals such as radioiodine decay in a predictable way and emit radiation while that is happening.

Bearing that principle in mind, researchers can make custom types of radioactive chemicals – or radioisotopes – that will attack cancer cells in a more efficient way than current cancer treatments.

Ruth will discuss his results at the American Association for the Advancement of Science (AAAS) conference in San Francisco, which runs from Feb. 15 to 19.

“Individual therapy means patients will require fewer radiation doses and treatment sessions,” says Ruth, who is director of the TRIUMF PET (Positron Emission Tomography) program at the University of British Columbia. “And the patient isn’t the only one who benefits. Doctors do not have to spend as much time treating patients, and hospitals will spend less money helping those patients get better.”

The challenge for Ruth and the rest of his team, who use the element rhenium for treatments, is separating the right isotope of rhenium with the accelerator. They buy the most common type from MDS Nordion in Kanata, Ontario, or the University of Missouri Research Reactor Center. At present they are investigating methods to ionize, or break apart, the rhenium. In the next phase of the project, they will use magnets to separate the specific type of rhenium they need – Rhenium 186.

“Right now, getting Rhenium 186 is a difficult and expensive process,” says Ruth. “The key is to make this practical for the people who need to use it. In the next few months, we will partner with local hospitals and begin pre-clinical trials – and, in the meantime, improve on the way we extract it to make it easy to purchase and cheap to use.”
###

Other partners in this venture include Technomedics of North Vancouver and the Prostate Centre at Vancouver

Thomas Ruth
TRIUMF
Vancouver, BC
Tel.: 604-222-5726
E-mail:

Natural Sciences and Engineering Research Council

RELATED STORIES:
Imaging Technology May Relieve Cancer Pain   How Eating Red Meat Can Spur Cancer Progression   Brits denied new targeted bowel cancer drugs   Doctors call for end to five cancer tests, treatments   Quality of life with cancer can be preserved   Taking a pill to fight cancer? Avoid these dangerous drug interactions   Cancer rates on the rise in young people   Cancer may require simpler genetic mutations than previously thought   Cancer will kill 13.2 million a year by 2030: U.N.   Risk of cancer increases with exposure to low-dose radiation   Cancer patients often forget details of doctor visit   Simple life changes could stop millions of cancers   Botox Could Help Target Resistant Tumors for Treatment   Van Andel Research Institute Finding Could Lead to Reduced Side Effects in Anti-Cancer Antibiotics   Statins don’t protect against cancer: study   Rate of Secondary Cancers Increases Over Years After Treatment for Childhood Leukemia   Study shows gene positions may aid cancer diagnosis   Preventing cancer without killing cells   Search for cancer genes unlikely to be successful   Regulators dispute finding of cancer-causing soda   Disabling Skp2 Gene Helps Shut Down Cancer Growth   Halting Cancer Metastasis

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]